-
Socioeconomic Status and Anti-obesity Medications: Impact on Cardiovascular Risk in Medicare Patients with Obesity
Mar 10, 2025, 14:00 PM -
Psychosocial Distress and Quality of Life Among Minority Men Diagnosed with Prostate Cancer: A Systematic Review
Mar 10, 2025, 14:00 PM -
Association Between Initiation of ENDS and Cigarette Smoking Reduction: A Causal Time Zero Approach to the PATH Study
Mar 10, 2025, 14:00 PM -
AI-Driven Evidence Synthesis: Leveraging RAG and Multi-Agentic Approach to Conduct Disease Landscape Assessments
Mar 10, 2025, 14:00 PM -
The Unseen Progress: How PROs May Overlook the Value of Slowing Degenerative Decline
Mar 10, 2025, 14:00 PM -
Trends In Oral JAK Inhibitor And Other Drug Use For Myelofibrosis: A Retrospective Real-World Study
Mar 10, 2025, 14:00 PM -
Economic Analysis of the Use of Polyhexamethylene Biguanide Associated with Betaine (PHMB) Gel Compared to Silver Sulfadiazine in the Treatment of Second-Degree Burns
Mar 10, 2025, 14:00 PM -
What Is the Level of Agreement between Family Caregivers and Their Children Living with Rheumatic Disease in Reporting Health-Related Quality of Life?
Mar 10, 2025, 14:00 PM -
Prognostic or Predictive Factors in Biliary Tract Cancer: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Evaluating Thresholds for Minimal Clinically Important Difference (MCID) in Patient-Reported Outcome Measures (PROMs) in Locally Advanced or Metastatic Urothelial Cancer (la/mUC): a Systematic Literature Review (SLR)
Mar 10, 2025, 14:00 PM -
Impact of Polatuzumab Vedotin as First-Line Therapy for DLBCL on Subsequent Treatments: Brazilian Model
Mar 10, 2025, 14:00 PM -
Exploring Treatment Preferences for Rare Diseases: A Systematic Review of Quantitative Preference Studies
Mar 10, 2025, 14:00 PM -
Burden Of Hidradenitis Suppurativa In The Brazilian Private Healthcare System
Mar 10, 2025, 14:00 PM -
Clinical Trial Participant and Clinician Experience in a Phase 2 (US-only) Trial of MM120 for Generalized Anxiety Disorder
Mar 10, 2025, 14:00 PM -
Therapeutic Options for Changing the Course of Disease in Generalized Myasthenia Gravis (gMG) and Fiscal Consequences for the Canadian Governments
Mar 10, 2025, 14:00 PM -
A Cluster Analysis to Identify Predictors and Profiles of Financial Hardship Among Cancer Patients in the United States
Mar 10, 2025, 14:00 PM -
Short- and Longer-Term Healthcare Resource Utilization and Related Costs of Stroke in the Brazilian Private Market from 2019 to 2023
Mar 10, 2025, 14:00 PM -
Impacts of the Inflation Reduction Act on 2025 Formulary Coverage in Medicare Part D Plans
Mar 10, 2025, 14:00 PM -
Clinical and Economic Impact of RBT-1 on Post-Operative Complications and Costs of Cardiac Surgery
Mar 10, 2025, 14:00 PM -
The Equitable Quality-Adjusted Life-Year
Mar 10, 2025, 14:00 PM
